VTAK News and Press, Catheter Precision Inc.

2026-03-10 10:03:39 ET Denver, Colorado - Markets open the session with strategic partnerships, infrastructure consolidation, and breakthrough technologies dominating the corporate news cycle; several companies are positioning themselves at the intersection of innovation and scalable ...

A look at the top 10 most actives in the United States Elong Power Holding Limited (ELPW) fell 98.3% to $0.0637 on volume of 253,817,455 shares BioRestorative Therapies Inc (BRTX) rose 24.9% to $0.2897 on volume of 120,689,016 shares Signing Day Sports Inc. (SGN) rose 39.6% to $0.7541 on vo...

2026-03-10 09:12:50 ET More on Creatd, Catheter Precision Seeking Alpha’s Quant Rating on Creatd Financial information for Creatd Seeking Alpha’s Quant Rating on Catheter Precision Financial information for Catheter Precision Read the ...

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Cre...

Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead of Industry-Wide eVTOL Commercialization FORT MILL, S.C., March 10, 2026 (GLOBE NEWSWIRE) -...

FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the  Int...

FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive agreement to divest its atherectomy catheter technologies, including associated FDA approval...

Strategic Partnership: Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary. Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions. Innovation in Aviation: Fly Flyte...

Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital Allocation into High-Growth Infrastructure with Scalable Fleet Expansion and Long-Term Equity...

VTAK has Agreed to Terminate its At-The-Market (“ATM”) Equity Offering Program Company Strengthens Balance Sheet and Aligns Institutional Capital for Long-Term Value Creation FORT MILL, S.C., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VT...